Effects of RAS inhibitors on all-site cancers and mortality in the Hong Kong diabetes surveillance database (2002-2019)

Effects of RAS inhibitors on all-site cancers and mortality in the Hong Kong diabetes surveillance database (2002-2019)

Summary: Background: Cancer is replacing cardiovascular-disease as a leading cause of death in type 2 diabetes (T2D). The association of RAS-inhibitors (RASi) and cancer, including differences between angiotensin-converting-enzyme-inhibitor (ACEi) and angiotensin-receptor-blocker (ARBs) as well as...

Full description

Bibliographic Details
Main Authors: Aimin Yang, Hongjiang Wu, Eric S.H. Lau, Mai Shi, Baoqi Fan, Alice Pik-Shan Kong, Ronald Ching-Wan Ma, Andrea On-Yan Luk, Juliana Chung-Ngor Chan, Elaine Chow
Format: Article
Language:English
Published: Elsevier 2022-09-01
Series:EBioMedicine
Subjects:
Angiotensin-converting enzyme inhibitors
Angiotensin receptor antagonists
Cancer
Mortality
Therapeutics
Diabetes
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396422004017

Internet

http://www.sciencedirect.com/science/article/pii/S2352396422004017

Similar Items